Key result
COVID-19 pandemic linked to ~28% drop in ACS admissions vs. 2019.
Why the study?
The impact of the COVID-19 pandemic on admissions of patients with ACS and PPCI in countries participating in the Stent-Save a Life global initiative needed to be assessed.
Cross-Sectional
Yes
Answers are grounded in this paper and cite their sources.
Observational survey shows reduced coronary admissions and primary percutaneous interventions, suggesting collateral healthcare disruption.
To assess the impact of the COVID-19 pandemic on admissions of patients with acute coronary syndromes (ACS) and primary percutaneous coronary intervention (PPCI) in countries participating in the Stent-Save a Life (SSL) global initiative. We conducted a multicenter observational survey to collect data on patient admissions for ACS, ST-elevation myocardial infarction (STEMI) and PPCI in participating SSL member countries through a period during the COVID-19 outbreak (March and April 2020) compared with the equivalent period in 2019. Of the 32 member countries of the SSL global initiative, 17 agreed to participate in the survey (three in Africa, five in Asia, six in Europe and three in Latin America). Overall reductions of 27.5% and 20.0% were observed in admissions for ACS and STEMI, respectively. The decrease in PPCI was 26.7%. This trend was observed in all except two countries. In these two, the pandemic peaked later than in the other countries. This survey shows that the COVID-19 outbreak was associated with a significant reduction in hospital admissions for ACS and STEMI as well as a reduction in PPCI, which can be explained by both patient- and system-related factors. Avaliar o impacto da pandemia COVID-19 nas admissões de doentes com síndromes coronárias agudas (SCA) e angioplastia coronária primária (PPCI) em países que participam da iniciativa global Stent-Save a Life (SSL). Realizámos estudo observacional multicêntrico para coletar dados sobre admissões de doentes por ACS, STEMI e PPCI nos países participantes no SSL durante um período do surto COVID-19 (março e abril de 2020) em comparação com o período homólogo de 2019. Dos 32 países membros da iniciativa global SSL, 17 aceitaram participar no estudo (3 de África, 5 da Ásia, 6 da Europa e 3 da América Latina (LATAM)). Observámos uma redução global de 27,5% e 20,0% nos internamentos com SCA e STEMI, respetivamente. A diminuição do PPCI foi de 26,7%. Essa tendência foi observada em todos os países, exceto dois. Nestes dois países, a pandemia atingiu o pico mais tarde do que nos restantes. Este estudo mostra que o surto de COVID-19 foi associado a uma redução significativa de admissões hospitalares por SCA e STEMI, bem como uma redução de PPCI, o que pode ser explicado por fatores relacionados com o doente e com o sistema.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2021) conducted a cross-sectional in Acute coronary syndromes (ACS) and ST-elevation myocardial infarction (STEMI). COVID-19 pandemic period (March and April 2020) vs. Pre-pandemic equivalent period (March and April 2019) was evaluated on Change in hospital admissions for ACS, STEMI, and primary percutaneous coronary intervention (PPCI) procedures. The COVID-19 pandemic period (March-April 2020) was associated with reductions of 27.5% in ACS admissions, 20.0% in STEMI admissions, and 26.7% in PPCI procedures compared to 2019.
Synapse has enriched 10 related papers. Consider them for comparative context: